Michael Faber joined the Edison Oncology Board of Directors in September 2026. He is a corporate executive, director, family office advisor, and attorney with more than 25 years of experience investing in, operating, and advising public and private companies across a range of industries.
Since 1996, Mr. Faber has served as President and Chief Investment Officer of NextPoint Management Company, Inc., a multi-billion-dollar single family office. Earlier in his career, he was a general partner of the NextPoint family of investment funds, where he focused on private equity, venture capital, and structured and private credit investments.
Mr. Faber has led investments in more than 180 companies, served as CEO of eight companies, and served on the boards of more than 40 private and public companies. He currently serves as a director of CPI Aerostructures, Inc. (NYSE: CVU) and Disciplined Growth Acquisition Corp. (Nasdaq: DGAC), and advises families and family offices on investment strategy, governance, and family office management.
Earlier in his career, Mr. Faber practiced law at Arnold & Porter and served as a senior consultant to The Research Council of Washington, the predecessor to The Corporate Executive Board Company. He is an honors graduate and John M. Olin Fellow of the University of Chicago Law School and attended the Johns Hopkins University School of Advanced International Studies and the State University of New York.